Contact
Please use this form to send email to PR contact of this press release:
FDA approves Erbitux to treat late-stage head and neck cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA approves Erbitux to treat late-stage head and neck cancer
TO: